Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 7/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19981311 | 1.00 | USP2 (0.45) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL587730 | 1.00 | USP2 (0.45) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL598942 | 1.00 | USP2 (0.45) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL6739408 | 1.00 | USP2 (0.45) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL28890368 | 0.92 | USP2 (0.44) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL7420375 | 0.87 | SLC7A5 (0.50) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL755924 | 0.87 | SLC7A5 (0.50) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL1168875 | 0.87 | SLC7A5 (0.50) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL28319949 | 0.85 | SLC7A5 (0.48) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 | |
| SCHEMBL28319951 | 0.85 | SLC7A5 (0.48) | USP2SLCO1B1SLC7A5SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100323955-A1 | METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERS | AMYLIN PHARMACEUTICALS, INC. (US) | 2010-12-23 | — | — | US | disclosed |